MARKET

ONCY

ONCY

Oncolytics Biotech Inc
NASDAQ
0.5666
-0.0316
-5.28%
Closed 17:57 04/23 EDT
OPEN
0.6082
PREV CLOSE
0.5982
HIGH
0.6100
LOW
0.5600
VOLUME
259.97K
TURNOVER
--
52 WEEK HIGH
1.530
52 WEEK LOW
0.4679
MARKET CAP
49.07M
P/E (TTM)
-1.9612
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ONCY last week (0414-0418)?
Weekly Report · 3d ago
Weekly Report: what happened at ONCY last week (0407-0411)?
Weekly Report · 04/14 10:27
Stocks in play: Oncolytics Biotech Inc
Barchart · 04/11 12:45
Oncolytics Biotech Secures $20 Million Funding for Pelareorep Development
TipRanks · 04/10 23:07
ONCOLYTICS BIOTECH INC - UNDER AGREEMENT, CAN SELL UP TO $20 MLN IN STOCK TO ALUMNI
Reuters · 04/10 22:09
Oncolytics Biotech’s Pelareorep Gains Attention at Key Oncology Event
TipRanks · 04/10 11:38
Stocks in play: Oncolytics Biotech Inc
Barchart · 04/10 08:41
Weekly Report: what happened at ONCY last week (0331-0404)?
Weekly Report · 04/07 10:26
More
About ONCY
More
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
Recently
Symbol
Price
%Change

Webull offers Oncolytics Biotech Inc (USA) stock information, including NASDAQ: ONCY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCY stock methods without spending real money on the virtual paper trading platform.